Clinical trial
Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture
NCT02475187 is registered in ClinicalTrials.gov with Vestre Viken Hospital Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture
- Lead sponsor
- Vestre Viken Hospital Trust
- Phase
- Observational
- Overall status
- Terminated
- Start date
- September 30, 2015
- Completion date
- February 1, 2018
- Enrollment
- 33 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.